145 related articles for article (PubMed ID: 25296601)
1. Expression of DNA cytosine deaminase APOBEC3 proteins, a potential source for producing mutations, in gastric, colorectal and prostate cancers.
Gwak M; Choi YJ; Yoo NJ; Lee S
Tumori; 2014; 100(4):112e-7e. PubMed ID: 25296601
[TBL] [Abstract][Full Text] [Related]
2. Mutational and expressional analyses of MYD88 gene in common solid cancers.
Je EM; Kim SS; Yoo NJ; Lee SH
Tumori; 2012; 98(5):663-9. PubMed ID: 23235763
[TBL] [Abstract][Full Text] [Related]
3. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
Lackey L; Law EK; Brown WL; Harris RS
Cell Cycle; 2013 Mar; 12(5):762-72. PubMed ID: 23388464
[TBL] [Abstract][Full Text] [Related]
6. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract][Full Text] [Related]
7. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
8. The roles of APOBEC3B in gastric cancer.
Zhang J; Wei W; Jin HC; Ying RC; Zhu AK; Zhang FJ
Int J Clin Exp Pathol; 2015; 8(5):5089-96. PubMed ID: 26191203
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
Stenglein MD; Harris RS
J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
11. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers.
Ahn CH; Jeong EG; Lee JW; Kim MS; Kim SH; Kim SS; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1344-9. PubMed ID: 18184403
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
[TBL] [Abstract][Full Text] [Related]
13. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.
Refsland EW; Stenglein MD; Shindo K; Albin JS; Brown WL; Harris RS
Nucleic Acids Res; 2010 Jul; 38(13):4274-84. PubMed ID: 20308164
[TBL] [Abstract][Full Text] [Related]
14. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3B is an enzymatic source of mutation in breast cancer.
Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
[TBL] [Abstract][Full Text] [Related]
17. Frameshift mutation of WISP3 gene and its regional heterogeneity in gastric and colorectal cancers.
Lee JH; Choi YJ; Je EM; Kim HS; Yoo NJ; Lee SH
Hum Pathol; 2016 Apr; 50():146-52. PubMed ID: 26997449
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas.
Beckler A; Moskaluk CA; Zaika A; Hampton GM; Powell SM; Frierson HF; El-Rifai W
Cancer; 2003 Oct; 98(7):1547-51. PubMed ID: 14508844
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
